COVID-19 has brought science to the forefront of policymaking around the world, and science advisers have become minor celebrities. Now, the public demands the experts are consulted, says Canada’s chief science adviser
EU director of public health calls for better pandemic preparedness, as health commissioner tells Science|Business conference that vaccine rollout is ‘gathering pace’
Politicians should not overlook the role played by basic research in a year of rapid vaccine development, says Nobel prize winner and neuroscientist Edvard Moser
The Horizon Europe start, a new international research strategy, EU Presidency plans, epidemic preparedness and more from 3 commissioners, 2 ministers, and many others... all in our Feb 22-23 conference tapes
Power systems will have to change if we are to achieve the goals set out by the European Green Deal. But while innovation is a much-needed step to reach carbon neutrality, the right approach in the digitalisation strategy must be adopted with a central figure and a watchword in mind: end-users and interoperability
The EU-funded ATTRACT project is piloting a powerful way to train young innovators – and supply the talent that Europe will need for success in emerging technologies
Partly in response to the pandemic, the European Commission has proposed creating a new agency – the Health Emergency Preparedness and Response Authority (HERA). What should it do? Who will fund it?
The European Commission has invested €469 million in 105 COVID-19 research projects, with funding for 45 clinical trials taking the biggest share, of €118.9 million, according to the latest data.
Association agreements will have broad provisions that are the same for all countries, but the process of concluding them is slow because each agreement needs to reflect differing political and economic relationships
To boost infectious disease research post-pandemic, Europe should emulate the Crick’s dual approach of running basic research in parallel with translating discoveries to treatments, saysNobel prize winner Michael Houghton
Science|Business launches an inquiry into how we can better manage the amazing fruits of science and technology in an age of pandemics, climate change and global turmoil
As the US rejoins the Paris agreement, Ernest J. Moniz, former US energy secretary, urges bigger budgets, broader ambitions for climate technologies. ‘We need to know which of these dogs can hunt by 2030’
EU research commissioner vows to avoid interruptions in the flow of EU R&D funding amid delayed rollout, as she outlines plan for stricter rules for international research cooperation, to reflect ‘geopolitical changes’
Money will fund sequencing to pick up dangerous variants and trials network to test updated vaccines. Vaccines approvals will be eased and supply contracts modified. The initiatives are a dry run for the proposed Health Emergency Preparedness and Response Authority
The new government promises to increase R&D spending to 2% of GDP. Researchers say this needs to be accompanied by reforms. There should be more competitive calls and a new independent council to increase transparency and reduce political interference, they say
Brexit put the brakes on investment for years, but champions of the tech say there is now a chance to make up ground. A new £130M research centre is on the way and plans for the first gigafactory are in hand
Oceans have enormous capacity to supply the earth with clean, renewable energy. Are we ready to harness this potential at global level, and what will be required to do so? A new Science|Business report explores the options.
Since COVID-19, EU leaders are pushing for greater independence from US and Chinese technology. Industry and researchers warn against closing Europe’s arms to the rest of the world. This special report decodes the debate
The Science|Business’ “Digital skills for industry” group brought together a unique group of stakeholders from industry, academia and policy. The group met twice, in January and June, in the course of 2020. This report is the summary of the discussions held during the events
The pandemic has hugely amplified the importance of measuring health outcomes – both in Europe and beyond. Which steps can health leaders take to embed this in the heart of post-COVID systems and policies? A new Science|Business guide explores the options.